Stopping Maintenance Therapy
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
- Myeloma Service
- 19-422
What will happen during the trial?
This study will test whether stopping maintenance therapy in people with multiple myeloma in MRD-negative remission has the same effect on disease control as continuing this therapy. The study will look at whether people currently on maintenance therapy can safely stop this treatment and continue with active surveillance instead while keeping their MRD-negative remission status for at least 1 year.
More Information
- Trial Status
- Accepting patients
- Enrollment
- 50 patients (estimated)
- Sponsors
- Memorial Sloan Kettering Cancer Center
- Tags
- Maintenance
- Trial Type
- Observational
- Last Update
- 4 weeks ago
- SparkCures ID
- 1066
- NCT Identifier
- NCT04221178
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.